acetylcysteine has been researched along with Infections, Staphylococcal in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (18.75) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 9 (56.25) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Chen, W; Hu, L; Lan, L; Li, B; Li, J; Li, X; Lin, D; Liu, W; Liu, Y; Lu, Y; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Xu, Y; Zheng, X; Zhu, J | 1 |
Chen, F; Hu, L; Lan, L; Li, B; Li, J; Mao, F; Ni, S; Qiu, X; Wang, M; Wei, H; Zheng, X; Zhu, J | 1 |
Chiaverini, L; Cirri, D; Di Luca, M; La Mendola, D; Marrone, A; Marzo, T; Nardinocchi, A; Pratesi, A; Tolbatov, I | 1 |
Cho, SI; Jo, ER; Jun, Y; Youn, CK | 1 |
Brisbois, EJ; Chug, MK; Kumar, R; Massoumi, H | 1 |
Kuruoglu, E; Kuruoglu, T; Onger, ME; Turan, DB | 1 |
Berkova, N; Cauty, C; Deplanche, M; Diot, A; Dutertre, S; Ezan, F; Götz, F; Langouet, S; Laurent, F; Le Loir, Y; Legembre, P; Mouhali, N; Nguyen, MT; Otto, M; Raulin, L; Taieb, F | 1 |
Fratita, M; Owens, R; O’Dwyer, M; Spring, A | 1 |
Amani, A; Fazly Bazzaz, BS; Khameneh, B; Rostami, J; Vahdati-Mashhadian, N | 1 |
Aslam, S; Darouiche, RO; Hernandez, MD; Mansouri, MD; Zeluff, B | 1 |
Aslam, S; Darouiche, R; Ghannoum, M; Jenne, K; Mehta, R; Reed, S | 1 |
De Vecchi, E; Drago, L; Mattina, R; Romanò, CL | 1 |
REAS, HW | 1 |
Albers, FW; Busscher, HJ; Schwandt, LQ; Stokroos, I; Van der Mei, HC; Van Weissenbruch, R | 1 |
Ostler, HB | 1 |
Chandrasekar, PH; Sluchak, JA | 1 |
16 other study(ies) available for acetylcysteine and Infections, Staphylococcal
Article | Year |
---|---|
Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Bacterial; Ether-A-Go-Go Potassium Channels; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Structure-Activity Relationship; Vancomycin; Vancomycin Resistance; Xanthophylls | 2017 |
Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Oxidoreductases; Piperonyl Butoxide; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2018 |
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation.
Topics: Acetylcysteine; Anti-Bacterial Agents; Auranofin; Humans; Staphylococcal Infections; Staphylococcus aureus | 2022 |
In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electrochemical, Scanning; Middle Ear Ventilation; Prostheses and Implants; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Staphylococcal Infections | 2019 |
Topics: Acetylcysteine; Anti-Bacterial Agents; Catheter-Related Infections; Catheters, Indwelling; Escherichia coli; Escherichia coli Infections; Esters; Humans; Staphylococcal Infections; Staphylococcus aureus | 2021 |
In Vitro Activity of Linezolid, Daptomycin and N-acetylcysteine Agents on Staphylococcus Aureus Biofilms in the Ventriculoperitoneal Shunt Model.
Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Daptomycin; In Vitro Techniques; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Ventriculoperitoneal Shunt | 2019 |
Staphylococcus aureus induces DNA damage in host cell.
Topics: Acetylcysteine; Arthritis, Infectious; Bacterial Toxins; Cell Line, Tumor; DNA Damage; DNA Repair; Etoposide; G2 Phase Cell Cycle Checkpoints; Genomic Islands; Guanine; HeLa Cells; Histones; Host-Pathogen Interactions; Humans; Lipoproteins; Osteitis; Osteoblasts; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Staphylococcal Infections; Staphylococcus aureus | 2019 |
An Under-Recognised Cause of Iatrogenic, Severe Metabolic Acidosis
Topics: Acetaminophen; Acetylcysteine; Acidosis; Aged, 80 and over; Anti-Bacterial Agents; Antipyretics; Arthroplasty, Replacement, Hip; Blood Gas Analysis; Drug Interactions; Floxacillin; Hip Prosthesis; Humans; Iatrogenic Disease; Male; Prosthesis-Related Infections; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Renal Replacement Therapy; Severity of Illness Index; Sodium Bicarbonate; Staphylococcal Infections; Surgical Wound Infection | 2019 |
Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
Topics: Acetylcysteine; Antitubercular Agents; Ascorbic Acid; Drug Synergism; Drug Therapy, Combination; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tuberculosis | 2016 |
Efficacy of combination of N-acetylcysteine, gentamicin, and amphotericin B for prevention of microbial colonization of ventricular assist devices.
Topics: Acetylcysteine; Amphotericin B; Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Disease Models, Animal; Equipment Contamination; Gentamicins; Heart-Assist Devices; Humans; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2009 |
N-acetylcysteine lock solution prevents catheter-associated bacteremia in rabbits.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Colony Count, Microbial; Disease Models, Animal; Female; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2012 |
Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
Topics: Acetylcysteine; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Load; Biofilms; Joint Prosthesis; Microbial Sensitivity Tests; Microscopy, Confocal; Polyethylene; Prosthesis Design; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Titanium | 2013 |
THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.
Topics: Acetylcysteine; Adolescent; Child; Cysteine; Cystic Fibrosis; Humans; Infant; Klebsiella; Lung Diseases; Pneumonia; Proteus Infections; Pseudomonas Infections; Pulmonary Emphysema; Radiography, Thoracic; Respiratory Function Tests; Respiratory Therapy; Spirometry; Staphylococcal Infections | 1964 |
Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat.
Topics: Acetylcysteine; Bacterial Adhesion; Biofilms; Candidiasis; Cultured Milk Products; Expectorants; Humans; Larynx, Artificial; Microscopy, Electron, Scanning; Prosthesis-Related Infections; Staphylococcal Infections; Streptococcal Infections | 2004 |
Corneal perforation in nontuberculous (staphylococcal) phlyctenular keratoconjunctivitis.
Topics: Acetylcysteine; Adolescent; Adrenal Cortex Hormones; Atropine; Blepharitis; Contact Lenses; Corneal Ulcer; Culture Techniques; Humans; Keratoconjunctivitis; Male; Ophthalmic Solutions; Sodium; Staphylococcal Infections; Sulfacetamide; Time Factors | 1975 |
Susceptibility of staphylococci to paldimycin, and emergence of resistance, in vitro.
Topics: Acetylcysteine; Anti-Bacterial Agents; Disaccharides; Drug Resistance, Microbial; Glycopeptides; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 1989 |